Abstract
Polycythemia vera and essential thrombocythemia comprise myeloproliferative neoplasms, the main characteristic of which is an over-production of bone marrow myeloid lineage cells. The diseases typically involve thrombosis and their treatment, apart from the strictly hematological aspect, involves antithrombotic agents. In this review we aspire to present the possible role of the newly developed oral anticoagulants in the treatment scheme of polycythemia vera and essential thrombocythemia.
Keywords: Essential thrombocythemia, novel oral anticoagulants, polycythemia vera.
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia
Volume: 12 Issue: 1
Author(s): Vasiliki Karali and Panayiotis Panayiotidis
Affiliation:
Keywords: Essential thrombocythemia, novel oral anticoagulants, polycythemia vera.
Abstract: Polycythemia vera and essential thrombocythemia comprise myeloproliferative neoplasms, the main characteristic of which is an over-production of bone marrow myeloid lineage cells. The diseases typically involve thrombosis and their treatment, apart from the strictly hematological aspect, involves antithrombotic agents. In this review we aspire to present the possible role of the newly developed oral anticoagulants in the treatment scheme of polycythemia vera and essential thrombocythemia.
Export Options
About this article
Cite this article as:
Karali Vasiliki and Panayiotidis Panayiotis, Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia, Cardiovascular & Hematological Agents in Medicinal Chemistry 2014; 12 (1) . https://dx.doi.org/10.2174/187152571201141201092923
DOI https://dx.doi.org/10.2174/187152571201141201092923 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atypical Presentation Of Anti-Retroviral Therapy Induced Lactic Acidosis as Acute Right Ventricular Failure And Severe Pulmonary Hypertension
New Emirates Medical Journal The Effects of Angiotensin II Signaling Blockade on Platelet Activity in Subjects with Hypertension
Current Hypertension Reviews The Effect of Local Alcohol Delivery in Reducing Intimal Hyperplasia Induced by Vascular Injury and the Clinical Implications
Vascular Disease Prevention (Discontinued) Hypertension in Peripheral Arterial Disease
Current Pharmaceutical Design Correlation of Salusin Beta with hs-CRP and ADMA in Hypertensive Children and Adolescents
Current Pharmaceutical Design Peironimev-Plus® in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronie’s Disease). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Current Cardiology Reviews Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases
Current Pharmaceutical Design Perioperative Considerations in Patients with Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker?
Current Pharmaceutical Design Preface
Current Enzyme Inhibition Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Anti-Apoptotic Effect of Human Telomerase Reverse Transcriptase on Endothelial Cells under Oxidative Stress, Independent of Telomere Elongation and Telomerase Activity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2
Coronaviruses Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan
Current Drug Delivery Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Neurotransmission Alterations in Central Cardiovascular Control in Experimental Hypertension
Current Hypertension Reviews Telmisartan Inhibits Advanced Glycation End Products (AGEs)-Elicited Endothelial Cell Injury by Suppressing AGE Receptor (RAGE) Expression Via Peroxisome Proliferator-Activated Receptor-γ Activation
Protein & Peptide Letters Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...
Current Pharmaceutical Design